Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Journal of Clinical Pharmacology|June 15, 2017
Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: BiologicsVera S Donnenberg, Maja Mandic, John C Rhee, et al.Molecular Cancer Therapeutics|November 24, 2017
Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal CancerGuangming Chen, Chenxi Gao, Xuan Gao, et al.Cancer Biology & Therapy|November 15, 2006
Insulin-like growth factor factor binding protein-2 is a novel mediator of p53 inhibition of insulin-like growth factor signalingAdda Grimberg, Carrie M Coleman, Zonggao Shi, et al.Journal of Hematology|April 18, 2020
Combined Modality Treatment With Brentuximab Vedotin and Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: A Case ReportErin G Floyd, Timothy F Burns, Konstantinos Linos, et al.The Journal of Clinical Endocrinology and Metabolism|March 17, 2005
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxiaAdda Grimberg, Carrie M Coleman, Timothy F Burns, et al.Cancer|March 26, 2013
The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinomaLiza C Villaruz, Mark A Socinski, Diana E Cunningham, et al.BMC Cancer|February 19, 2024
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancerAbdulkader Yassin-Kassab, Suman Chatterjee, Nayel Khan, et al.Breast Cancer Research and Treatment|February 25, 2019
SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinomaEmily A Bossart, Nilgun Tasdemir, Matthew J Sikora, et al.Cell & Bioscience|October 10, 2024
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinomaSuet Kee Loo, Gabriel Sica, Xian Wang, et al.NPJ Precision Oncology|November 4, 2023
Lorlatinib and capmatinib in a ROS1-rearranged NSCLC with MET-driven resistance: tumor response and evolutionJaime L Schneider, Khvaramze Shaverdashvili, Mari Mino-Kenudson, et al.Pageof 7